Emergency physician at Doctors Hospital in Columbus, Ohio
BIOGRAPHY
Event Date & Time
Date: October 20, 2022
Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST)
Abstract
Bacterial and viral infections produce a wide range of similar signs and symptoms leading often to the inappropriate use of antibiotics. Close to 2.8 million people in the United States get an antibiotic-resistant infection each year, and approximately 30% of antibiotic prescriptions are thought to be unnecessary. Inappropriate prescription rates and overuse have led to antibiotic resistance which has created a global health emergency that has shown to be responsible for approximately 700,000 deaths a year worldwide. By the year 2050, the number is expected to reach 10 million worldwide according to WHO. Biomarker technologies such as Procalcitonin appears to be a cost effective and safe remedy for this dilemma.
In this webinar, Dr. James F. Neuenschwander II, MD, FACEP, FASAM, will describe PCT-aided antibiotic stewardship, provide insights on why PCT is considered a catalyst and how Is PCT compared to other tests. He will also be sharing the economic benefits and value drivers of PCT testing that have the most impact.
Learning Objectives
- Discuss PCT-aided antibiotic stewardship in sepsis and lower respiratory tract infections (LRTI)
- Illustrate the impact of PCT on the emergency and ICU department decision making
- Demonstrate the economic benefits of PCT.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...